Funded Health Care Startups in Germany
Among 50 recent Germany-based health care rounds, the largest disclosed amount is InflaRx’s $30M (2025-02-13).
Among 50 recent Germany-based health care rounds, the largest disclosed amount is InflaRx’s $30M (2025-02-13). That single figure is well above the next-highest disclosed rounds visible here, including Smart Reporting’s $25M (2024-04-22) and Avelios Medical’s $31M is just slightly higher at $31M (2025-02-06), while most other disclosed rounds cluster in single-digit millions (for example $11M at apoQlar on 2024-05-05; $9M at Kranus Health on 2023-10-02; and $8M at Berlin Heals on 2025-02-18). Outlier-wise, undisclosed deal sizes are common: 19 of 50 entries are marked “undisclosed,” including Arab Therapy (2025-09-21) and Prosoma (2025-06-16), which makes disclosed-value comparisons skew toward the minority with stated amounts.
Geographically, Berlin is a clear concentration point across multiple entries and dates, including Arab Therapy (2025-09-21), Berlin Heals (2025-02-18), and Selfapy (2023-02-17), while Munich appears repeatedly as well (e.g., Avelios Medical on 2025-02-06; XO Life on 2024-08-22; Smart4Diagnostics on 2023-05-09). Temporally, rounds extend from 2023-02-01 (Recovery Cat) through 2025-09-21 (Arab Therapy), with a heavy run of activity in 2025, including several disclosed deals in the $4M–$8M range such as Elea ($4M, 2025-03-12), Mallia Innovations ($6M, 2025-06-04), and HelloBetter ($6M, 2025-03-05).
Most recent rounds
50 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Germany health care list, and how does it stack up against the rest?
The largest disclosed amount shown is Avelios Medical’s $31M (2025-02-06), with InflaRx’s $30M (2025-02-13) as the next-largest. Several other disclosed rounds sit far lower, including Smart Reporting at $25M (2024-04-22) and multiple single-digit million rounds such as Elea ($4M, 2025-03-12) and DiaMonTech GmbH (undisclosed, 2023-12-07).
Are disclosed amounts concentrated in a narrow range, or do they show clear outliers besides the top two?
Beyond Avelios Medical ($31M, 2025-02-06) and InflaRx ($30M, 2025-02-13), the visible disclosed deals cluster largely in the $1M–$11M band—for instance, apoQlar’s $11M (2024-05-05) and Kranus Health’s $9M (2023-10-02). Smaller disclosed entries like Sanvivo at $500K (2023-04-05) also anchor the lower edge.
Do specific cities dominate these rounds, suggesting a geographic cluster?
Berlin appears repeatedly across different deal types and dates, including Arab Therapy (2025-09-21, undisclosed), Berlin Heals ($8M, 2025-02-18), and Selfapy ($7M, 2023-02-17). Munich also recurs with multiple entries such as Avelios Medical ($31M, 2025-02-06) and Smart4Diagnostics ($4M, 2023-05-09), indicating city-level repetition rather than a single isolated location.
How much of the list has undisclosed amounts, and does that affect value-based comparisons?
Undisclosed deal sizes are widespread: 19 of 50 rows are marked “undisclosed,” including Arab Therapy (2025-09-21) and Prosoma (2025-06-16). That means the largest-vs-rest discussion is driven by the subset with disclosed amounts, where the top end is $30M–$31M.
Which period looks most active within the date window shown (oldest to most recent)?
Rounds span from 2023-02-01 (Recovery Cat) to 2025-09-21 (Arab Therapy), with a noticeable concentration in 2025. The 2025-02-06 to 2025-02-13 window alone includes large disclosed rounds like Avelios Medical ($31M, 2025-02-06) and InflaRx ($30M, 2025-02-13), while earlier entries in 2023 show more limited disclosed amounts such as Sanvivo ($500K, 2023-04-05) and Careloop ($2M, 2023-02-13).
Is there a stage mix pattern (or notable stage names) that stands out across the most recent entries?
Stage labels are varied, with many entries categorized as Seed, while “Series Unknown” also appears frequently (e.g., Berlin Heals on 2025-02-18; Lykon on 2023-08-17). Among explicitly numbered stages, Series A and Series B show up alongside notable disclosed deals such as Smart Reporting’s Series C ($25M, 2024-04-22) and Kranus Health’s Series A ($9M, 2023-10-02).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.